Going beyond serology for stratifying the risk of CMV infection in transplant recipients
D Navarro, M Fernández‐Ruiz… - Reviews in Medical …, 2019 - Wiley Online Library
Knowledge of donor and recipient (D/R) cytomegalovirus (CMV) serostatus is critical for risk
stratification of CMV infection and disease in transplant recipients, particularly in the solid …
stratification of CMV infection and disease in transplant recipients, particularly in the solid …
[HTML][HTML] Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update
K Prakash, A Chandorkar, KK Saharia - Diagnostics, 2021 - mdpi.com
Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …
Increasing proportion of high-risk cytomegalovirus donor-positive/recipient-negative serostatus in solid organ transplant recipients
H Imlay, MM Wagener, P Vutien, J Perkins… - …, 2023 - journals.lww.com
Background. Cytomegalovirus (CMV) donor-positive/recipient-negative (D+ R–) serostatus
is independently associated with worse allograft and patient survival across solid organ …
is independently associated with worse allograft and patient survival across solid organ …
Clinical utility of a cytomegalovirus‐specific T cell assay in assessing the risk of post‐prophylaxis cytomegalovirus infection and post‐treatment relapse
MV Dioverti, E Bhaimia, ZA Yetmar… - Clinical …, 2023 - Wiley Online Library
Introduction Cytomegalovirus (CMV) causes significant morbidity in solid organ transplant
recipients (SOTR). Measuring cell‐mediated immunity (CMI) may inform the risk of CMV …
recipients (SOTR). Measuring cell‐mediated immunity (CMI) may inform the risk of CMV …
[引用][C] It's not too late: a proposal to standardize the terminology of “late‐onset” cytomegalovirus infection and disease in solid organ transplant recipients
RR Razonable, EA Blumberg - Transplant Infectious Disease, 2015 - Wiley Online Library
Despite remarkable improvements in its diagnosis, prevention, and treatment,
cytomegalovirus (CMV) remains the single most important pathogen after solid organ …
cytomegalovirus (CMV) remains the single most important pathogen after solid organ …
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a …
Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient …
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient …
[HTML][HTML] Cytomegalovirus cell-mediated immunity: ready for routine use?
O Bestard, H Kaminski, L Couzi… - Transplant …, 2023 - frontierspartnerships.org
Utilizing assays that assess specific T-cell-mediated immunity against cytomegalovirus
(CMV) holds the potential to enhance personalized strategies aimed at preventing and …
(CMV) holds the potential to enhance personalized strategies aimed at preventing and …
CMV-specific T-cells and CD27-CD28-CD4+ T-cells for assignment of cytomegalovirus (CMV) status in adults awaiting organ transplant
Abstract Background/objectives: Determination of Cytomegalovirus (CMV) status in solid
organ transplant (SOT) candidates is essential to stratify risk of post-transplant CMV disease …
organ transplant (SOT) candidates is essential to stratify risk of post-transplant CMV disease …
[HTML][HTML] Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study
A Molina-Ortega, C Martín-Gandul… - Clinical Microbiology …, 2019 - Elsevier
Introduction Although solid organ transplant (SOT) recipients with pretransplant serology for
cytomegalovirus (CMV-R+) are considered at intermediate risk for CMV infection post …
cytomegalovirus (CMV-R+) are considered at intermediate risk for CMV infection post …
Risk factors for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis
AA Boudreault, H Xie, RM Rakita… - Transplant Infectious …, 2011 - Wiley Online Library
AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …